FIGURE

Fig. 8

ID

ZDB-FIG-221114-22

Publication

Harms et al., 2021 - An optimized derivative of an endogenous CXCR4 antagonist prevents atopic dermatitis and airway inflammation

Other Figures

All Figure Page

Back to All Figure Page

Fig. 8

Stability of EPI-X4 JM#21 in human plasma. 20 μmol/L of EPI-X4 JM#21 was diluted in 100% human plasma. The mixture was incubated at 37 °C and samples taken at indicated time points and stored at −80 °C. Samples were thawed in parallel, serially diluted in PBS and activity determined by 12G5-antibody competition. IC₅₀ values were determined by non-linear regression and remaining activity calculated by IC₅₀ (t = 0)/IC₅₀ (t) × 100. Data were represented as mean ± SEM (n = 3).

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Acta Pharm Sin B